Title:
USE OF PIPERAZINE FERULATE TABLETS
Document Type and Number:
WIPO Patent Application WO/2021/135071
Kind Code:
A1
Abstract:
Disclosed is a use of piperazine ferulate tablets in the preparation of medicaments for preventing and treating anemia. The piperazine ferulate tablets can obviously improve the content of erythropoietin and further promote bone marrow to generate erythrocyte, and hence can be used for preventing and treating anemia caused by chronic kidney diseases.
Inventors:
CHEN JIANPING (CN)
WANG FOZHANG (CN)
LIU XINHUI (CN)
HUANG SHIYING (CN)
ZHENG PING (CN)
ZHENG LIN (CN)
ZHANG SHANGBIN (CN)
LI SHUNMIN (CN)
WANG FOZHANG (CN)
LIU XINHUI (CN)
HUANG SHIYING (CN)
ZHENG PING (CN)
ZHENG LIN (CN)
ZHANG SHANGBIN (CN)
LI SHUNMIN (CN)
Application Number:
PCT/CN2020/094276
Publication Date:
July 08, 2021
Filing Date:
June 04, 2020
Export Citation:
Assignee:
SHENZHAN TRADITIONAL CHINESE MEDICINE HOSPITAL (CN)
International Classes:
A61K31/192; A61K31/495; A61P7/06
Foreign References:
| CN110420215A | 2019-11-08 | |||
| CN101904893A | 2010-12-08 | |||
| CN110812428A | 2020-02-21 |
Other References:
GU HONGJING, FENG SHENGGANG: "Research Progress on the Mechanism of Piperazine Ferulate on Diabetic Kidney Disease", MEDICAL JOURNAL OF WEST CHINA, vol. 31, no. 10, 1 October 2019 (2019-10-01), pages 1637 - 1640, XP055826828, ISSN: 1672-3511, DOI: 10.3969/j.issn.1672-3511.2019.10.033
WEI DONGHONG, ZHAO GUI-DONG;YU MIN;JIANG BEI: "Clinical Efficacy and Safety of Piperazine Ferulate Combined with Irbesartan in the Treatment of Diabetic Nephropathy", ZHONGGUO LINCHUANG YAOLIXUE ZAZHI - CHINESE JOURNAL OF CLINICALPHARMACOLOGY, ZHONGGUI YAOXUEHUI, BEIJING,, CN, vol. 32, no. 4, 1 February 2016 (2016-02-01), CN, pages 294 - 296, XP055826831, ISSN: 1001-6821, DOI: 10.13699/j.cnki.1001-6821.2016.04.002
DENG RONG-RONG, LIANG-YUAN YAO, DA-XIONG XIANG: "Pharmacological effect of piperazine ferulate", ZHONG NAN YAO XUE, CN, vol. 16, no. 11, 1 November 2018 (2018-11-01), CN, pages 1575 - 1578, XP055826834, ISSN: 1672-2981, DOI: 10.7539/j.issn.1672-2981.2018.11.015
WEI DONGHONG, ZHAO GUI-DONG;YU MIN;JIANG BEI: "Clinical Efficacy and Safety of Piperazine Ferulate Combined with Irbesartan in the Treatment of Diabetic Nephropathy", ZHONGGUO LINCHUANG YAOLIXUE ZAZHI - CHINESE JOURNAL OF CLINICALPHARMACOLOGY, ZHONGGUI YAOXUEHUI, BEIJING,, CN, vol. 32, no. 4, 1 February 2016 (2016-02-01), CN, pages 294 - 296, XP055826831, ISSN: 1001-6821, DOI: 10.13699/j.cnki.1001-6821.2016.04.002
DENG RONG-RONG, LIANG-YUAN YAO, DA-XIONG XIANG: "Pharmacological effect of piperazine ferulate", ZHONG NAN YAO XUE, CN, vol. 16, no. 11, 1 November 2018 (2018-11-01), CN, pages 1575 - 1578, XP055826834, ISSN: 1672-2981, DOI: 10.7539/j.issn.1672-2981.2018.11.015
Attorney, Agent or Firm:
BORSAM INTELLECTUAL PROPERTY LTD. (CN)
Download PDF:
Previous Patent: AUTOMATIC FILM CUTTING AND BOTTLE FEEDING MACHINE
Next Patent: PROBE AND DETECTION KIT FOR DETECTING LUNG CANCER DRIVING GENE MUTATION
Next Patent: PROBE AND DETECTION KIT FOR DETECTING LUNG CANCER DRIVING GENE MUTATION